Literature DB >> 27452954

Comparative analysis of biologic versus synthetic mesh outcomes in contaminated hernia repairs.

Arnab Majumder1, Joshua S Winder2, Yuxiang Wen1, Eric M Pauli2, Igor Belyansky3, Yuri W Novitsky4.   

Abstract

BACKGROUND: Contaminated operative fields pose significant challenges for surgeons performing ventral hernia repair. Although biologic meshes have been utilized increasingly in these fields, recent evidence suggests that synthetic meshes represent a viable option. We analyzed the outcomes of biologic and synthetic mesh utilized in patients undergoing major ventral hernia repair in clean-contaminated/contaminated fields.
METHODS: We conducted a multicenter, retrospective review of patients undergoing open ventral hernia repair in clean-contaminated/contaminated fields using biologic or synthetic mesh. Patient and hernia details were characterized. Primary outcomes included 90-day surgical site event, surgical site infection, and hernia recurrence.
RESULTS: A total of 126 patients undergoing major ventral hernia repair in clean-contaminated/contaminated fields (69 biologic and 57 synthetic meshes) were analyzed. Groups were similar in both patient and hernia characteristics. There were 13 (22.8%) surgical site events in the synthetic cohort compared to 29 (42.0%) in the biologic cohort, P = .024. Similarly, surgical site infections were less frequent in the synthetic group, with 7 (12.3%) vs 22 (31.9%), P = .01. With a mean follow-up of 20 months, there were more recurrences in the biologic group: 15 (26.3%) vs 4 (8.9%) in the synthetic group, P = .039.
CONCLUSION: The choice of mesh for clean-contaminated/contaminated ventral hernia repair remains debatable. We demonstrated that using synthetic sublay mesh resulted in a significantly lower wound morbidity and more durable outcomes versus a similar cohort of biologic repairs. This is likely secondary to improved bacterial clearance and faster integration of macroporous synthetics. Overall, our findings not only support suitability of synthetic mesh in contaminated settings but also challenge the purported advantage of biologics in clean-contaminated/contaminated ventral hernia repairs.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27452954     DOI: 10.1016/j.surg.2016.04.041

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  43 in total

1.  SSI, SSO, SSE, SSOPI: the elusive language of complications in hernia surgery.

Authors:  J DeBord; Y Novitsky; R Fitzgibbons; M Miserez; A Montgomery
Journal:  Hernia       Date:  2018-09-10       Impact factor: 4.739

2.  Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional Hernia.

Authors:  Yohann Renard; Louis de Mestier; Julie Henriques; Paul de Boissieu; Philippe de Mestier; Abe Fingerhut; Jean-Pierre Palot; Reza Kianmanesh
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

3.  Ventral hernia repair with poly-4-hydroxybutyrate mesh.

Authors:  Margaret A Plymale; Daniel L Davenport; Adam Dugan; Amanda Zachem; John Scott Roth
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

4.  Decellularization and In Vivo Recellularization of Abdominal Porcine Fascial Tissue.

Authors:  Julio C Sánchez; Diana M Díaz; Leidy V Sánchez; Aníbal Valencia-Vásquez; Juan F Quintero; Laura V Muñoz; Andrés F Bernal; Germán Osorio; Álvaro Guerra; Juliana Buitrago
Journal:  Tissue Eng Regen Med       Date:  2020-11-24       Impact factor: 4.169

5.  Incidence of Incisional Hernia After Emergency Subcostal Unilateral Laparotomy: Does Augmentation Prophylaxis Play a Role?

Authors:  A Bravo-Salva; A M González-Castillo; F F Vela-Polanco; E Membrilla-Fernández; J Vila-Domenech; M Pera-Román; J J Sancho-Insenser; J A Pereira-Rodríguez
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

6.  Impact of incisional hernia development following abdominal operations on total healthcare cost.

Authors:  Vamsi V Alli; Jianying Zhang; Dana A Telem
Journal:  Surg Endosc       Date:  2017-12-12       Impact factor: 4.584

7.  Perioperative and midterm outcomes of emergent robotic repair of incarcerated ventral and incisional hernia.

Authors:  Omar Yusef Kudsi; Naseem Bou-Ayash; Karen Chang; Fahri Gokcal
Journal:  J Robot Surg       Date:  2020-07-28

8.  Single-center ventral hernia repair with porcine dermis collagen implant.

Authors:  M Boules; A T Strong; R Corcelles; I N Haskins; R Ilie; C Wathen; D Froylich; G Sharma; J Rodriguez; S Rosenblatt; K El-Hayek; M Kroh
Journal:  Surg Endosc       Date:  2017-09-20       Impact factor: 4.584

9.  Comparison of biological and alloplastic meshes in ventral incisional hernia repair.

Authors:  A Koscielny; S Widenmayer; T May; J Kalff; P Lingohr
Journal:  Langenbecks Arch Surg       Date:  2017-12-06       Impact factor: 3.445

10.  First human use of hybrid synthetic/biologic mesh in ventral hernia repair: a multicenter trial.

Authors:  James G Bittner; Kevin El-Hayek; Andrew T Strong; Melissa Phillips LaPinska; Jin S Yoo; Eric M Pauli; Matthew Kroh
Journal:  Surg Endosc       Date:  2017-07-19       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.